NCT07323875

Brief Summary

Achilles insertional tendinopathy may require surgical debridement and tendon reattachment when non-operative treatment fails. Single-row and double-row repairs are used, with biomechanical studies favoring double-row, but clinical evidence of improved outcomes is lacking and costs are higher. This multi-center randomized trial will use the VISA-A score to compare outcomes and inform cost-effective, evidence-based surgical care.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
166

participants targeted

Target at P75+ for not_applicable

Timeline
47mo left

Started Feb 2026

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress6%
Feb 2026Mar 2030

First Submitted

Initial submission to the registry

November 28, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 7, 2026

Completed
25 days until next milestone

Study Start

First participant enrolled

February 1, 2026

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2028

Expected
2.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2030

Last Updated

January 8, 2026

Status Verified

December 1, 2025

Enrollment Period

2 years

First QC Date

November 28, 2025

Last Update Submit

January 6, 2026

Conditions

Keywords

single row repairdouble row repaircalcaneal insertion

Outcome Measures

Primary Outcomes (1)

  • Disease-specific outcomes

    The Victorian Institute of Sport Assessment-Achilles (VISA-A) questionnaire is a validated, self-reported outcome measure designed to assess the severity of Achilles tendinopathy. It evaluates three key domains: pain, function, and activity level and produces a score from 0 to 100, with higher scores indicating better function and fewer symptoms.

    24 months after surgery

Secondary Outcomes (7)

  • Surgical Cost

    Within 2 hours of surgery

  • Foot and Ankle Ability Measure (FAAM)

    24 months after surgery

  • Visual Analogue Scale Foot and ankle (VAS-FA)

    24 months after surgery

  • Plantarflexion strength

    24 months after surgery

  • Biomechanical performance

    24 months after surgery

  • +2 more secondary outcomes

Study Arms (2)

Single-row repair Arm

ACTIVE COMPARATOR

Single-row repair will involve 2 suture anchors (2 anchors total)

Procedure: Single-row repair of the Achilles tendon at its calcaneal insertion

Double-row repair Arm

ACTIVE COMPARATOR

Double-row repair will involve 2 suture anchors for the proximal row and 2 suture anchors for the distal row (4 anchors total)

Procedure: Double-row repair of the Achilles tendon at its calcaneal insertion

Interventions

single-row (2 anchors)

Single-row repair Arm

double-row (4 anchors)

Double-row repair Arm

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Must be deemed to have capacity to provide informed consent;
  • Must sign and date the informed consent form;
  • Stated willingness to comply with all study procedures;
  • Adult patients between the ages of 18 and 75 years with symptomatic chronic Achilles insertional tendinopathy for a minimum of 3 months
  • Failure of non-operative management (which includes physiotherapy, stretching exercises, heel lifts, nonsteroidal anti-inflammatory drugs (NSAIDs), activity modification, etc.) for at least 3 months.
  • Preoperative imaging (x-ray and Medical Resonance Imaging (MRI)) is available and completed;
  • Willingness of patients to follow the postoperative rehabilitation protocol;
  • Willingness of patients to be available for follow up appointments for up to 2 years.

You may not qualify if:

  • Non-insertional Achilles tendinopathy;
  • Achilles tendon rupture;
  • Previous Achilles tendon surgery;
  • Oral steroid use or steroid injection within 3 months of surgery;
  • History of connective tissue or collagen disorder (e.g. Marfan Syndrome)
  • History of chronic inflammatory disorders
  • History of neurological disease (stroke, cerebral palsy)
  • History of using more than 30mg of oxycodone or equivalent per day;
  • Current cigarette smoker (Former smokers must have quit for minimum of one year)
  • Diabetes type I or II
  • Pregnancy
  • Hypersensitivity to metal, Polylactic Acid (PLA), or Polyetheretherketone (PEEK) materials
  • Active infection
  • Worker's compensation claim (e.g. WSIB)
  • History of cognitive or mental health conditions that would make the participant unable to complete study procedures
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Women's College Hospital

Toronto, Ontario, M5S 1B2, Canada

Location

Study Officials

  • Si-Hyeong Sam Park, MD, FRCPC

    Women's College Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
As noted above, only the surgeon will be aware of allocation assignment. The participant and outcomes assessors will be blinded to minimize bias.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This study is a prospective randomized controlled clinical trial of patients undergoing surgical management for chronic Achilles insertional tendinopathy.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD MASc FRCPC

Study Record Dates

First Submitted

November 28, 2025

First Posted

January 7, 2026

Study Start

February 1, 2026

Primary Completion (Estimated)

February 1, 2028

Study Completion (Estimated)

March 1, 2030

Last Updated

January 8, 2026

Record last verified: 2025-12

Locations